{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T07:19:57Z","timestamp":1787555997370,"version":"build-2736575974"},"reference-count":117,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2023M732809"],"award-info":[{"award-number":["2023M732809"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32460186"],"award-info":[{"award-number":["32460186"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32200522"],"award-info":[{"award-number":["32200522"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32360156"],"award-info":[{"award-number":["32360156"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Phytomedicine"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.phymed.2026.158701","type":"journal-article","created":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T00:36:35Z","timestamp":1786322195000},"page":"158701","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Chelerythrine and chelidonine synergistically target the adenosine pathway to improve anti-PD-L1 immunotherapy efficacy in lung cancer"],"prefix":"10.1016","volume":"160","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6666-0912","authenticated-orcid":false,"given":"Jinglin","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruifei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiangna","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuru","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruijie","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenni","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haixia","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0781-9735","authenticated-orcid":false,"given":"Liang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengtao","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunli","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.phymed.2026.158701_bib0001","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1007\/s12035-017-0548-9","article-title":"Immune alterations in CD8+ T cells are associated with neuronal CC and CXC chemokine receptor regulation through adenosine A2A receptor signaling in a BTBR T+ Itpr3tf\/J autistic mouse model","volume":"55","author":"Ahmad","year":"2018","journal-title":"Mol. Neurobiol."},{"issue":"1","key":"10.1016\/j.phymed.2026.158701_bib0002","article-title":"Hypoxia-inducible factors as an alternative source of treatment strategy for cancer","volume":"2019","author":"Akanji","year":"2019","journal-title":"Oxidative Med. Cell. Longev."},{"issue":"10","key":"10.1016\/j.phymed.2026.158701_bib0003","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/s41571-020-0382-2","article-title":"The adenosine pathway in immuno-oncology","volume":"17","author":"Allard","year":"2020","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.phymed.2026.158701_bib0004","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.coph.2016.04.001","article-title":"Immunosuppressive activities of adenosine in cancer","volume":"29","author":"Allard","year":"2016","journal-title":"Curr. Opin. Pharmacol."},{"issue":"20","key":"10.1016\/j.phymed.2026.158701_bib0005","doi-asserted-by":"crossref","first-page":"5626","DOI":"10.1158\/1078-0432.CCR-13-0545","article-title":"Targeting CD73 enhances the antitumor activity of anti-PD-1 and anti-CTLA-4 mAbs","volume":"19","author":"Allard","year":"2013","journal-title":"Clin. Cancer Res."},{"issue":"13_Supplement","key":"10.1016\/j.phymed.2026.158701_bib0006","doi-asserted-by":"crossref","first-page":"2862","DOI":"10.1158\/1538-7445.AM2021-2862","article-title":"BMP4 mediated suppression of cholesterol synthesis and breast cancer metastasis","volume":"81","author":"Anderson","year":"2021","journal-title":"Cancer Res."},{"issue":"5","key":"10.1016\/j.phymed.2026.158701_bib0007","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.3324\/haematol.2019.242016","article-title":"Targeting the A2A adenosine receptor counteracts immunosuppression in vivo in a mouse model of chronic lymphocytic leukemia","volume":"106","author":"Arruga","year":"2021","journal-title":"Haematologica"},{"issue":"10","key":"10.1016\/j.phymed.2026.158701_bib0008","doi-asserted-by":"crossref","first-page":"6820","DOI":"10.1007\/s12035-019-1538-x","article-title":"Reference gene validation via RT\u2013qPCR for human iPSC-derived neural stem cells and neural progenitors","volume":"56","author":"Augustyniak","year":"2019","journal-title":"Mol. Neurobiol."},{"issue":"12","key":"10.1016\/j.phymed.2026.158701_bib0009","doi-asserted-by":"crossref","first-page":"2632","DOI":"10.1038\/s41423-021-00796-4","article-title":"Distinct roles but cooperative effect of TLR3\/9 agonists and PD-1 blockade in converting the immunotolerant microenvironment of irreversible electroporation-ablated tumors","volume":"18","author":"Babikr","year":"2021","journal-title":"Cell. Mol. Immunol."},{"issue":"2","key":"10.1016\/j.phymed.2026.158701_bib0010","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3390\/biom11020147","article-title":"NTPDase1 modulates smooth muscle contraction in mice bladder by regulating nucleotide receptor activation distinctly in male and female","volume":"11","author":"Babou Kammoe","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.phymed.2026.158701_bib116","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1016\/j.ijbiomac.2019.09.078","article-title":"Adenosine deaminase inhibition[J]","volume":"141","author":"Bagheri","year":"2019","journal-title":"Int. J. Biol. Macromol."},{"issue":"5","key":"10.1016\/j.phymed.2026.158701_bib0011","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1002\/ijc.29519","article-title":"HIF-1 at the crossroads of hypoxia, inflammation, and cancer","volume":"138","author":"Balamurugan","year":"2016","journal-title":"Int. J. Cancer"},{"issue":"5","key":"10.1016\/j.phymed.2026.158701_bib0012","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1158\/2326-6066.CIR-14-0211","article-title":"Adenosine receptor 2A blockade increases the efficacy of anti\u2013PD-1 through enhanced antitumor T-cell responses","volume":"3","author":"Beavis","year":"2015","journal-title":"Cancer Immunol. Res."},{"issue":"10.1158","key":"10.1016\/j.phymed.2026.158701_bib0013","first-page":"1538","article-title":"Evidence of immune activation in the first-in-human phase Ia dose escalation study of the adenosine 2a receptor antagonist, AZD4635, in patients with advanced solid tumors","volume":"79","author":"Bendell","year":"2019","journal-title":"Cancer Res."},{"issue":"13","key":"10.1016\/j.phymed.2026.158701_bib0014","first-page":"2602","article-title":"The extracellular fluid of solid carcinomas contains immunosuppressive concentrations of adenosine","volume":"57","author":"Blay","year":"1997","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.phymed.2026.158701_bib0015","doi-asserted-by":"crossref","DOI":"10.2202\/1544-6115.1075","article-title":"PLS dimension reduction for classification with microarray data","volume":"3","author":"Boulesteix","year":"2004","journal-title":"Stat. Appl. Genet. Mol. Biol."},{"issue":"5","key":"10.1016\/j.phymed.2026.158701_bib0016","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/BF01919318","article-title":"Accumulation of purine catabolites in solid tumors exposed to therapeutic hyperthermia","volume":"52","author":"Busse","year":"1996","journal-title":"Experientia"},{"key":"10.1016\/j.phymed.2026.158701_bib0017","article-title":"Rediscovery of traditional plant medicine: an underestimated anticancer drug of chelerythrine","volume":"13","author":"Chen","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"33","key":"10.1016\/j.phymed.2026.158701_bib0018","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202302498","article-title":"Tumor Microenvironment Responsive CD8+ T Cells and Myeloid-Derived Suppressor Cells to Trigger CD73 Inhibitor AB680-Based Synergistic Therapy for Pancreatic Cancer","volume":"10","author":"Chen","year":"2023","journal-title":"Adv. Sci."},{"issue":"6","key":"10.1016\/j.phymed.2026.158701_bib0019","doi-asserted-by":"crossref","first-page":"3917","DOI":"10.3892\/ol.2016.4520","article-title":"Chelerythrine chloride induces apoptosis in renal cancer HEK-293 and SW-839 cell lines","volume":"11","author":"Chen","year":"2016","journal-title":"Oncol. Lett."},{"issue":"2","key":"10.1016\/j.phymed.2026.158701_bib0020","first-page":"737","article-title":"In vitro and in vivo activity of protein kinase C inhibitor chelerythrine chloride induces tumor cell toxicity and growth delay in vivo","volume":"6","author":"Chmura","year":"2000","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.phymed.2026.158701_bib0021","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1158\/0008-5472.CAN-09-1947","article-title":"Using the Chou-Talalay method drug combination studies and their synergy quantification","volume":"70","author":"Chou","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.phymed.2026.158701_bib0022","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0065-2571(84)90007-4","article-title":"Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors","volume":"22","author":"Chou","year":"1984","journal-title":"Adv. Enzyme Regul."},{"issue":"4","key":"10.1016\/j.phymed.2026.158701_bib0023","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.humimm.2020.12.005","article-title":"Targeting adenosine and regulatory T cells in cancer immunotherapy","volume":"82","author":"Churov","year":"2021","journal-title":"Hum. Immunol."},{"issue":"2","key":"10.1016\/j.phymed.2026.158701_bib0024","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1046\/j.1440-1711.2000.00889.x","article-title":"Characterization of the ovalbumin-specific TCR transgenic line OT-I: MHC elements for positive and negative selection","volume":"78","author":"Clarke","year":"2000","journal-title":"Immunol. Cell Biol."},{"issue":"2","key":"10.1016\/j.phymed.2026.158701_bib111","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1006\/phrs.1996.0019","article-title":"Pharmacological activities ofchelidonium majusl.(papaveraceae)[J]","volume":"33","author":"Colombo","year":"1996","journal-title":"Pharmacol. Res."},{"issue":"9","key":"10.1016\/j.phymed.2026.158701_bib0025","doi-asserted-by":"crossref","first-page":"3623","DOI":"10.1021\/jm4011669","article-title":"Adenosine A2A receptor as a drug discovery target","volume":"57","author":"de Lera Ruiz","year":"2014","journal-title":"J. Med. Chem."},{"issue":"2","key":"10.1016\/j.phymed.2026.158701_bib0026","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/j.1365-3083.2010.02490.x","article-title":"Mitogenic response and cytokine production induced by cramoll 1, 4 lectin in splenocytes of inoculated mice","volume":"73","author":"De Melo","year":"2011","journal-title":"Scand. J. Immunol."},{"issue":"11","key":"10.1016\/j.phymed.2026.158701_bib0027","doi-asserted-by":"crossref","DOI":"10.1242\/jcs.237222","article-title":"BMP4 promotes the metastasis of gastric cancer by inducing epithelial\u2013mesenchymal transition via ID1","volume":"133","author":"Deng","year":"2020","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.phymed.2026.158701_bib0028","doi-asserted-by":"crossref","unstructured":"Deng, Z., Tian, H., Ding, Y., Jin, Q., Liu, Y., Liu, T., and Zhao, T. 2023. Virtual screening to investigate the potential targets and mechanisms of action of\" Astragalus-Ligustrum\" drug pair in the treatment of non-small cell lung cancer.","DOI":"10.21203\/rs.3.rs-3349225\/v1"},{"key":"10.1016\/j.phymed.2026.158701_bib0029","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/gb-2003-4-9-r60","article-title":"DAVID: database for annotation, visualization, and integrated discovery","volume":"4","author":"Dennis","year":"2003","journal-title":"Genome Biol."},{"issue":"6","key":"10.1016\/j.phymed.2026.158701_bib0030","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/s41571-021-00473-5","article-title":"PD-L1 as a biomarker of response to immune-checkpoint inhibitors","volume":"18","author":"Doroshow","year":"2021","journal-title":"Nat. rev. Clin. Oncol."},{"key":"10.1016\/j.phymed.2026.158701_bib0031","series-title":"Quality Control of Chinese Medicines: Strategies and Methods","first-page":"157","article-title":"Network Pharmacology to Clarify the Effective Substances and Their Action Mechanisms of Traditional Chinese Medicines","author":"Du","year":"2024"},{"issue":"15","key":"10.1016\/j.phymed.2026.158701_bib0032","doi-asserted-by":"crossref","first-page":"8375","DOI":"10.3390\/ijms25158375","article-title":"Natural alkaloids in cancer therapy: berberine, sanguinarine and chelerythrine against colorectal and gastric cancer","volume":"25","author":"Duda-Madej","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.phymed.2026.158701_bib0033","doi-asserted-by":"crossref","first-page":"24","DOI":"10.24218\/fnr.2015.04","article-title":"Aqueous extract from turmeric (Curcuma Longa) inhibits adenosine deaminase activity significantly in cancerous and non cancerous human gastric and colon tissues","volume":"1","author":"Durak","year":"2015","journal-title":"F Nutr. Reprt."},{"key":"10.1016\/j.phymed.2026.158701_bib0034","doi-asserted-by":"crossref","DOI":"10.1016\/j.it.2026.06.005","article-title":"Adenosine as a metabolic checkpoint in CD8+ T cell dysfunction","author":"Edgerton","year":"2026","journal-title":"Trends Immunol."},{"key":"10.1016\/j.phymed.2026.158701_bib0035","series-title":"Histopathology: Methods and Protocols","first-page":"31","article-title":"Tissue processing and hematoxylin and eosin staining","author":"Feldman","year":"2014"},{"issue":"5","key":"10.1016\/j.phymed.2026.158701_bib0036","doi-asserted-by":"crossref","DOI":"10.1101\/pdb.prot4986","article-title":"Hematoxylin and eosin staining of tissue and cell sections","volume":"2008","author":"Fischer","year":"2008","journal-title":"Cold Spring Harb. Protoc."},{"issue":"1","key":"10.1016\/j.phymed.2026.158701_bib0037","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1158\/2159-8290.CD-19-0980","article-title":"Adenosine 2A receptor blockade as an immunotherapy for treatment-refractory renal cell cancer","volume":"10","author":"Fong","year":"2020","journal-title":"Cancer Discov."},{"issue":"3","key":"10.1016\/j.phymed.2026.158701_bib0038","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s00109-013-1101-6","article-title":"Adenosine\u2014a physiological or pathophysiological agent?","volume":"92","author":"Fredholm","year":"2014","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.phymed.2026.158701_bib0039","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2025.118188","article-title":"Co-targeting the CD73-adenosinergic axis enhances the anti-tumor efficacy of anti-PD-L1 immunotherapy in bladder cancer","volume":"188","author":"Furriel","year":"2025","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.phymed.2026.158701_bib0040","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.bcp.2018.02.002","article-title":"Adenosine metabolism, immunity and joint health","volume":"151","author":"Hask\u00f3","year":"2018","journal-title":"Biochem. Pharmacol."},{"issue":"277","key":"10.1016\/j.phymed.2026.158701_bib0041","doi-asserted-by":"crossref","first-page":"277ra230","DOI":"10.1126\/scitranslmed.aaa1260","article-title":"Immunological mechanisms of the antitumor effects of supplemental oxygenation","volume":"7","author":"Hatfield","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.phymed.2026.158701_bib0042","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/j.ijbiomac.2021.11.155","article-title":"Synthesis and characterization of chitosan nanoparticles loaded with greater celandine (Chelidonium majus L.) essential oil as an anticancer agent on MCF-7 cell line","volume":"194","author":"Hesami","year":"2022","journal-title":"Int. J. Biol. Macromol."},{"issue":"1","key":"10.1016\/j.phymed.2026.158701_bib0043","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0092-8674(94)90169-4","article-title":"T cell receptor antagonist peptides induce positive selection","volume":"76","author":"Hogquist","year":"1994","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.phymed.2026.158701_bib0044","article-title":"Camphorataimide B suppresses the metastasis of human colorectal cancer cell by inhibiting Smad\/FAK\/Akt axis and promoting degradation of Snail\/BMP4 complex","volume":"30","author":"Huang","year":"2022","journal-title":"J. Food Drug Anal."},{"issue":"4","key":"10.1016\/j.phymed.2026.158701_bib0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2019.126913","article-title":"Design, synthesis and apoptosis-related antiproliferative activities of chelidonine derivatives","volume":"30","author":"Huang","year":"2020","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.phymed.2026.158701_bib0046","doi-asserted-by":"crossref","DOI":"10.1177\/15347354211006191","article-title":"Chelidonine induces apoptosis via GADD45a-p53 regulation in human pancreatic cancer cells","volume":"20","author":"Jang","year":"2021","journal-title":"Integr. Cancer Ther."},{"issue":"22","key":"10.1016\/j.phymed.2026.158701_bib110","doi-asserted-by":"crossref","first-page":"13444","DOI":"10.1021\/acs.jmedchem.0c01044","article-title":"Targeting metabolism of extracellular nucleotides via inhibition of ectonucleotidases CD73 and CD39[J]","volume":"63","author":"Jeffrey","year":"2020","journal-title":"J. Med. Chem."},{"issue":"16","key":"10.1016\/j.phymed.2026.158701_bib0047","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1038\/onc.2014.124","article-title":"SIRT3 regulates cellular iron metabolism and cancer growth by repressing iron regulatory protein 1","volume":"34","author":"Jeong","year":"2015","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.phymed.2026.158701_bib0048","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1186\/s12951-025-03500-0","article-title":"Targeting CD39 boosts PD-1 blockade antitumor therapeutic efficacy via strengthening CD8+ TILs function and recruiting B cells in cervical cancer","volume":"23","author":"Jiang","year":"2025","journal-title":"J. Nanobiotechnology"},{"issue":"1","key":"10.1016\/j.phymed.2026.158701_bib0049","doi-asserted-by":"crossref","DOI":"10.1080\/15384047.2023.2296048","article-title":"Efficacy and pharmacodynamic effect of anti-CD73 and anti-PD-L1 monoclonal antibodies in combination with cytotoxic therapy: observations from mouse tumor models","volume":"25","author":"Kaistha","year":"2024","journal-title":"Cancer Biol. Ther."},{"issue":"6","key":"10.1016\/j.phymed.2026.158701_bib0050","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.cancergen.2012.05.009","article-title":"Bone morphogenetic protein 4\u2014a fascinating regulator of cancer cell behavior","volume":"205","author":"Kallioniemi","year":"2012","journal-title":"Cancer Genet."},{"issue":"8_Supplement_1","key":"10.1016\/j.phymed.2026.158701_bib0051","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1158\/1538-7445.AM2025-1352","article-title":"Extracellular adenosine suppress CD8+ T cell attraction resulting in poor prognosis in pancreatic ductal adenocarcinoma","volume":"85","author":"Katsuta","year":"2025","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.phymed.2026.158701_bib0052","doi-asserted-by":"crossref","first-page":"782","DOI":"10.4049\/jimmunol.1700850","article-title":"A2A adenosine receptor gene deletion or synthetic A2A antagonist liberate tumor-reactive CD8+ T cells from tumor-induced immunosuppression","volume":"201","author":"Kjaergaard","year":"2018","journal-title":"J. Immunol."},{"issue":"17","key":"10.1016\/j.phymed.2026.158701_bib0053","doi-asserted-by":"crossref","first-page":"3859","DOI":"10.3390\/jcm10173859","article-title":"Decreased thrombospondin-1 and bone morphogenetic protein-4 serum levels as potential indices of advanced stage lung cancer","volume":"10","author":"Kosacka","year":"2021","journal-title":"J. Clin. Med."},{"issue":"4","key":"10.1016\/j.phymed.2026.158701_bib0054","doi-asserted-by":"crossref","first-page":"904","DOI":"10.4103\/0973-1482.143342","article-title":"Chelerythrine delayed tumor growth and increased survival duration of Dalton's lymphoma bearing BALB\/c H 2d mice by activation of NK cells in vivo","volume":"11","author":"Kumar","year":"2015","journal-title":"J. Cancer Res. Ther."},{"key":"10.1016\/j.phymed.2026.158701_bib0055","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1212209","article-title":"Inhibitors of the CD73-adenosinergic checkpoint as promising combinatory agents for conventional and advanced cancer immunotherapy","volume":"14","author":"Kurago","year":"2023","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.phymed.2026.158701_bib114","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1046\/j.1471-4159.2001.00607.x","article-title":"Adenosine in the central nervous system: release mechanisms and extracellular concentrations[J]","volume":"79","author":"Latini","year":"2001","journal-title":"J. Neurochem."},{"issue":"20","key":"10.1016\/j.phymed.2026.158701_bib0056","doi-asserted-by":"crossref","first-page":"11448","DOI":"10.1021\/acs.jmedchem.0c00525","article-title":"Discovery of AB680: a potent and selective inhibitor of CD73","volume":"63","author":"Lawson","year":"2020","journal-title":"J. Med. Chem."},{"issue":"8","key":"10.1016\/j.phymed.2026.158701_bib0057","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1007\/s00262-018-2186-0","article-title":"Inhibition of the adenosine A2a receptor modulates expression of T cell coinhibitory receptors and improves effector function for enhanced checkpoint blockade and ACT in murine cancer models","volume":"67","author":"Leone","year":"2018","journal-title":"Cancer Immunol. Immunother."},{"issue":"4","key":"10.1016\/j.phymed.2026.158701_bib0058","doi-asserted-by":"crossref","DOI":"10.1093\/bib\/bbac261","article-title":"Hiplot: a comprehensive and easy-to-use web service boosting publication-ready biomedical data visualization","volume":"23","author":"Li","year":"2022","journal-title":"Brief. Bioinform."},{"issue":"7","key":"10.1016\/j.phymed.2026.158701_bib0059","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.3390\/ph18071036","article-title":"Chelerythrine Inhibits TGF-\u03b2-Induced Epithelial\u2013Mesenchymal Transition in A549 Cells via RRM2","volume":"18","author":"Liu","year":"2025","journal-title":"Pharmaceuticals"},{"issue":"1","key":"10.1016\/j.phymed.2026.158701_bib0060","first-page":"1","article-title":"In silico-based screen synergistic drug combinations from herb medicines: a case using Cistanche tubulosa","volume":"7","author":"Liu","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.phymed.2026.158701_bib0061","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2025.157451","article-title":"Chelidonine-induced inhibition of FBP1 disrupts M2 macrophage polarization and attenuates breast cancer","author":"Liu","year":"2025","journal-title":"Phytomedicine"},{"issue":"1","key":"10.1016\/j.phymed.2026.158701_bib0062","doi-asserted-by":"crossref","first-page":"6740","DOI":"10.1038\/s41467-022-34495-z","article-title":"Single cell sequencing reveals that CD39 inhibition mediates changes to the tumor microenvironment","volume":"13","author":"Liu","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.phymed.2026.158701_bib0063","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2025.189443","article-title":"The CD39-CD73-adenosine axis: Master regulator of immune evasion and therapeutic target in pancreatic ductal adenocarcinoma","author":"Liu","year":"2025","journal-title":"Biochim. Biophys. Acta (BBA)-Rev. Cancer"},{"key":"10.1016\/j.phymed.2026.158701_bib0064","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.canlet.2022.01.027","article-title":"HIF-1\u03b1 inhibition promotes the efficacy of immune checkpoint blockade in the treatment of non-small cell lung cancer","volume":"531","author":"Luo","year":"2022","journal-title":"Cancer Lett."},{"issue":"35","key":"10.1016\/j.phymed.2026.158701_bib0065","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202405158","article-title":"Boron neutron capture therapy-derived extracellular vesicles via DNA accumulation boost antitumor dendritic cell vaccine efficacy","volume":"11","author":"Lv","year":"2024","journal-title":"Adv. Sci."},{"issue":"12","key":"10.1016\/j.phymed.2026.158701_bib0066","doi-asserted-by":"crossref","first-page":"2951","DOI":"10.3390\/cancers13122951","article-title":"Inhibiting endothelial cell function in normal and tumor angiogenesis using BMP type I receptor macrocyclic kinase inhibitors","volume":"13","author":"Ma","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.phymed.2026.158701_bib0067","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s12943-017-0665-0","article-title":"Blockade of adenosine A2A receptor enhances CD8+ T cells response and decreases regulatory T cells in head and neck squamous cell carcinoma","volume":"16","author":"Ma","year":"2017","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.phymed.2026.158701_bib0068","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40425-019-0719-5","article-title":"Adenosine mediates functional and metabolic suppression of peripheral and tumor-infiltrating CD8+ T cells","volume":"7","author":"Mastelic-Gavillet","year":"2019","journal-title":"J. Immunother. Cancer"},{"issue":"10","key":"10.1016\/j.phymed.2026.158701_bib0069","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1038\/nm.3952","article-title":"Combined inhibition of BET family proteins and histone deacetylases as a potential epigenetics-based therapy for pancreatic ductal adenocarcinoma","volume":"21","author":"Mazur","year":"2015","journal-title":"Nat. Med."},{"issue":"14","key":"10.1016\/j.phymed.2026.158701_bib0070","doi-asserted-by":"crossref","first-page":"3652","DOI":"10.1158\/0008-5472.CAN-14-0957","article-title":"Antimetastatic effects of blocking PD-1 and the adenosine A2A receptor","volume":"74","author":"Mittal","year":"2014","journal-title":"Cancer Res."},{"issue":"14","key":"10.1016\/j.phymed.2026.158701_bib0071","doi-asserted-by":"crossref","DOI":"10.1128\/MCB.00553-18","article-title":"Hypoxic environment promotes barrier formation in human intestinal epithelial cells through regulation of microRNA 320a expression","volume":"39","author":"Muenchau","year":"2019","journal-title":"Mol. Cell. Biol."},{"issue":"9","key":"10.1016\/j.phymed.2026.158701_bib0072","doi-asserted-by":"crossref","first-page":"485","DOI":"10.3390\/toxins11090485","article-title":"Cytotoxic and proapoptotic activity of sanguinarine, berberine, and extracts of Chelidonium majus L. and Berberis thunbergii DC. toward hematopoietic cancer cell lines","volume":"11","author":"Och","year":"2019","journal-title":"Toxins"},{"issue":"35","key":"10.1016\/j.phymed.2026.158701_bib0073","doi-asserted-by":"crossref","first-page":"13132","DOI":"10.1073\/pnas.0605251103","article-title":"A2A adenosine receptor protects tumors from antitumor T cells","volume":"103","author":"Ohta","year":"2006","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.phymed.2026.158701_bib0074","doi-asserted-by":"crossref","first-page":"304","DOI":"10.3389\/fimmu.2014.00304","article-title":"Extracellular adenosine-mediated modulation of regulatory T cells","volume":"5","author":"Ohta","year":"2014","journal-title":"Front. Immunol."},{"key":"10.1016\/j.phymed.2026.158701_bib0075","doi-asserted-by":"crossref","unstructured":"Overman, M.J., LoRusso, P., Strickler, J.H., Patel, S.P., Clarke, S.J., Noonan, A.M., Prasanna, T., Amin, M.A., Nemunaitis, J.J., and Desai, J. (2018). Safety, efficacy and pharmacodynamics (PD) of MEDI9447 (oleclumab) alone or in combination with durvalumab in advanced colorectal cancer (CRC) or pancreatic cancer (panc) (American Society of Clinical Oncology).","DOI":"10.1200\/JCO.2018.36.15_suppl.4123"},{"issue":"41","key":"10.1016\/j.phymed.2026.158701_bib117","doi-asserted-by":"crossref","first-page":"143","DOI":"10.4103\/0973-1296.149729","article-title":"Effects of aqueous extract from Silybum marianum on adenosine deaminase activity in cancerous and noncancerous human gastric and colon tissues[J]","volume":"11","author":"\u00d6zt\u00fcrk","year":"2015","journal-title":"Pharmacog. Mag."},{"issue":"4","key":"10.1016\/j.phymed.2026.158701_bib115","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s11302-018-9619-2","article-title":"Adenosine signaling and adenosine deaminase regulation of immune responses: impact on the immunopathogenesis of HIV infection[J]","volume":"14","author":"Passos","year":"2018","journal-title":"Purinerg. Signal."},{"issue":"6","key":"10.1016\/j.phymed.2026.158701_bib0076","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1158\/1535-7163.MCT-21-0802","article-title":"Targeting CD73 with AB680 (Quemliclustat), a novel and potent small-molecule CD73 inhibitor, restores immune functionality and facilitates antitumor immunity","volume":"21","author":"Piovesan","year":"2022","journal-title":"Mol. Cancer Ther."},{"issue":"7","key":"10.1016\/j.phymed.2026.158701_bib0077","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1080\/09603123.2021.1897534","article-title":"Chelidonium majus crude extract induces activation of peripheral blood mononuclear cells and enhances their cytotoxic effect toward HeLa cells","volume":"32","author":"Popovic","year":"2022","journal-title":"Int. J. Environ. Health Res."},{"issue":"1","key":"10.1016\/j.phymed.2026.158701_bib0078","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1758-2946-6-13","article-title":"TCMSP: a database of systems pharmacology for drug discovery from herbal medicines","volume":"6","author":"Ru","year":"2014","journal-title":"J. Cheminformatics"},{"key":"10.1016\/j.phymed.2026.158701_bib0079","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2018.01.036","article-title":"AB680, a potent and selective CD73 small molecule inhibitor, reverses the AMP\/adenosine-mediated impairment of immune effector cell activation by immune checkpoint inhibitors","volume":"92","author":"Schindler","year":"2018","journal-title":"Eur. J. Cancer"},{"issue":"10","key":"10.1016\/j.phymed.2026.158701_bib0080","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/nrc1187","article-title":"Targeting HIF-1 for cancer therapy","volume":"3","author":"Semenza","year":"2003","journal-title":"Nat. Rev. Cancer"},{"issue":"7","key":"10.1016\/j.phymed.2026.158701_bib0081","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2025.112841","article-title":"Identification of novel macrophages and bone morphogenetic protein signals causing ectopic calcification and impairing muscle regeneration","volume":"28","author":"Shi","year":"2025","journal-title":"iScience"},{"key":"10.1016\/j.phymed.2026.158701_bib0082","doi-asserted-by":"crossref","first-page":"162","DOI":"10.3389\/fimmu.2019.00162","article-title":"Adenosine A2A receptor stimulation inhibits TCR-induced Notch1 activation in CD8+ T-cells","volume":"10","author":"Sorrentino","year":"2019","journal-title":"Front. Immunol."},{"issue":"7","key":"10.1016\/j.phymed.2026.158701_bib113","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1172\/JCI0215337","article-title":"Ecto-5\u2032-nucleotidase (CD73) regulation by hypoxia-inducible factor-1 mediates permeability changes in intestinal epithelia[J]","volume":"110","author":"Synnestvedt","year":"2002","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.phymed.2026.158701_bib0083","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.taap.2016.11.016","article-title":"Protective role of hypoxia-inducible factor-1\u03b1-dependent CD39 and CD73 in fulminant acute liver failure","volume":"314","author":"Tak","year":"2017","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"27","key":"10.1016\/j.phymed.2026.158701_bib0084","doi-asserted-by":"crossref","first-page":"2754","DOI":"10.1111\/1759-7714.15059","article-title":"Investigation of response factors for monotherapy with immune checkpoint inhibitors in non-small cell lung cancer patients with PD-L1 expression< 50%","volume":"14","author":"Takahara","year":"2023","journal-title":"Thorac. Cancer"},{"issue":"W1","key":"10.1016\/j.phymed.2026.158701_bib0085","doi-asserted-by":"crossref","first-page":"W556","DOI":"10.1093\/nar\/gkz430","article-title":"GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis","volume":"47","author":"Tang","year":"2019","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"10.1016\/j.phymed.2026.158701_bib0086","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1146\/annurev-med-060619-023155","article-title":"Inhibition of the adenosine pathway to potentiate cancer immunotherapy: potential for combinatorial approaches","volume":"72","author":"Thompson","year":"2021","journal-title":"Annu. Rev. Med."},{"issue":"3","key":"10.1016\/j.phymed.2026.158701_bib0087","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.142843","article-title":"Anti\u2013PD-L1 and anti-CD73 combination therapy promotes T cell response to EGFR-mutated NSCLC","volume":"7","author":"Tu","year":"2022","journal-title":"JCI Insight"},{"issue":"7","key":"10.1016\/j.phymed.2026.158701_bib0088","doi-asserted-by":"crossref","first-page":"6360","DOI":"10.3390\/ijms24076360","article-title":"Determination of selected isoquinoline alkaloids from chelidonium majus, mahonia aquifolium and sanguinaria canadensis extracts by liquid chromatography and their In Vitro and In Vivo cytotoxic activity against human cancer cells","volume":"24","author":"Tuzimski","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.phymed.2026.158701_bib0089","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/s41590-022-01379-9","article-title":"Hypoxia drives CD39-dependent suppressor function in exhausted T cells to limit antitumor immunity","volume":"24","author":"Vignali","year":"2023","journal-title":"Nat. Immunol."},{"issue":"12","key":"10.1016\/j.phymed.2026.158701_bib0090","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/nrc.2017.86","article-title":"Targeting immunosuppressive adenosine in cancer","volume":"17","author":"Vijayan","year":"2017","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.phymed.2026.158701_bib0091","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.617316","article-title":"Evaluation of combination strategies for the A2AR inhibitor AZD4635 across tumor microenvironment conditions via a systems pharmacology model","volume":"12","author":"Voronova","year":"2021","journal-title":"Front. Immunol."},{"issue":"7","key":"10.1016\/j.phymed.2026.158701_bib0092","doi-asserted-by":"crossref","first-page":"3798","DOI":"10.21037\/tcr-24-972","article-title":"Integrating network pharmacology and computational biology to propose Yiqi Sanjie formula\u2019s mechanisms in treating NSCLC: molecular docking, ADMET, and molecular dynamics simulation","volume":"13","author":"Wang","year":"2024","journal-title":"Transl. Cancer Res."},{"issue":"1","key":"10.1016\/j.phymed.2026.158701_bib0093","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/j.1527-3466.1992.tb00235.x","article-title":"CGS 21680: a potent selective adenosine A2 receptor agonist","volume":"10","author":"Webb","year":"1992","journal-title":"Cardiovasc. Drug Rev."},{"issue":"1","key":"10.1016\/j.phymed.2026.158701_bib0094","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1186\/s13287-025-04422-2","article-title":"Short-Term DMOG treatment rejuvenates senescent mesenchymal stem cells by enhancing mitochondrial function and mitophagy through the HIF-1\u03b1\/BNIP3 pathway","volume":"16","author":"Wen","year":"2025","journal-title":"Stem Cell Res. Ther."},{"issue":"10","key":"10.1016\/j.phymed.2026.158701_bib0095","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1158\/2326-6066.CIR-18-0056","article-title":"A2AR antagonism with CPI-444 induces antitumor responses and augments efficacy to anti\u2013PD-(L) 1 and anti\u2013CTLA-4 in preclinical models","volume":"6","author":"Willingham","year":"2018","journal-title":"Cancer Immunol. Res."},{"issue":"suppl_1","key":"10.1016\/j.phymed.2026.158701_bib0096","doi-asserted-by":"crossref","first-page":"D668","DOI":"10.1093\/nar\/gkj067","article-title":"DrugBank: a comprehensive resource for in silico drug discovery and exploration","volume":"34","author":"Wishart","year":"2006","journal-title":"Nucleic Acids Res."},{"issue":"5","key":"10.1016\/j.phymed.2026.158701_bib0097","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/0009-9236(95)90168-X","article-title":"Differentiation of absorption and first-pass gut and hepatic metabolism in humans: studies with cyclosporine","volume":"58","author":"Wu","year":"1995","journal-title":"Clin. Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.phymed.2026.158701_bib112","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s12943-023-01733-x","article-title":"CD39\/CD73\/A2AR pathway and cancer immunotherapy[J]","volume":"22","author":"Xia","year":"2023","journal-title":"Molec. Cancer"},{"key":"10.1016\/j.phymed.2026.158701_bib0098","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.104934","article-title":"Chelidonine selectively inhibits the growth of gefitinib-resistant non-small cell lung cancer cells through the EGFR-AMPK pathway","volume":"159","author":"Xie","year":"2020","journal-title":"Pharmacol. Res."},{"issue":"6","key":"10.1016\/j.phymed.2026.158701_bib0099","doi-asserted-by":"crossref","first-page":"6964","DOI":"10.3390\/ijms13066964","article-title":"A novel chemometric method for the prediction of human oral bioavailability","volume":"13","author":"Xu","year":"2012","journal-title":"Int. J. Mol. Sci."},{"issue":"12","key":"10.1016\/j.phymed.2026.158701_bib0100","doi-asserted-by":"crossref","first-page":"i246","DOI":"10.1093\/bioinformatics\/btq176","article-title":"Drug-target interaction prediction from chemical, genomic and pharmacological data in an integrated framework","volume":"26","author":"Yamanishi","year":"2010","journal-title":"Bioinformatics"},{"issue":"15","key":"10.1016\/j.phymed.2026.158701_bib0101","doi-asserted-by":"crossref","first-page":"4026","DOI":"10.1158\/0008-5472.CAN-17-0112","article-title":"Autocrine BMP-4 signaling is a therapeutic target in colorectal cancer","volume":"77","author":"Yokoyama","year":"2017","journal-title":"Cancer Res."},{"issue":"8","key":"10.1016\/j.phymed.2026.158701_bib0102","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1158\/2159-8290.CD-14-0341","article-title":"Targeting cancer-derived adenosine: new therapeutic approaches","volume":"4","author":"Young","year":"2014","journal-title":"Cancer Discov."},{"issue":"5","key":"10.1016\/j.phymed.2026.158701_bib0103","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0037608","article-title":"A systematic prediction of multiple drug-target interactions from chemical, genomic, and pharmacological data","volume":"7","author":"Yu","year":"2012","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.phymed.2026.158701_bib0104","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1038\/nm.1888","article-title":"BMP type I receptor inhibition reduces heterotopic ossification","volume":"14","author":"Yu","year":"2008","journal-title":"Nat. Med."},{"issue":"4","key":"10.1016\/j.phymed.2026.158701_bib0105","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0018704","article-title":"Expression and distribution of ectonucleotidases in mouse urinary bladder","volume":"6","author":"Yu","year":"2011","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.phymed.2026.158701_bib0106","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/s12896-014-0112-x","article-title":"PHDs inhibitor DMOG promotes the vascularization process in the AV loop by HIF-1a up-regulation and the preliminary discussion on its kinetics in rat","volume":"14","author":"Yuan","year":"2014","journal-title":"BMC Biotechnol."},{"issue":"3","key":"10.1016\/j.phymed.2026.158701_bib0107","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.placenta.2014.12.019","article-title":"Discordant HIF1A mRNA levels and oxidative stress in placental shares of monochorionic twins with selective intra-uterine growth restriction","volume":"36","author":"Zhang","year":"2015","journal-title":"Placenta"},{"key":"10.1016\/j.phymed.2026.158701_bib0108","doi-asserted-by":"crossref","DOI":"10.1093\/abbs\/gmab148","article-title":"YTHDF2 is essential for spermatogenesis and fertility by mediating a wave of transcriptional transition in spermatogenic cells","author":"Zhao","year":"2021","journal-title":"Acta Biochim. Biophys. Sin."},{"issue":"1","key":"10.1016\/j.phymed.2026.158701_bib0109","article-title":"Large-scale direct targeting for drug repositioning and discovery","volume":"5","author":"Zheng","year":"2015","journal-title":"Sci. Rep."}],"container-title":["Phytomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711326009323?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711326009323?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T06:27:54Z","timestamp":1787552874000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0944711326009323"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":117,"alternative-id":["S0944711326009323"],"URL":"https:\/\/doi.org\/10.1016\/j.phymed.2026.158701","relation":{},"ISSN":["0944-7113"],"issn-type":[{"value":"0944-7113","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chelerythrine and chelidonine synergistically target the adenosine pathway to improve anti-PD-L1 immunotherapy efficacy in lung cancer","name":"articletitle","label":"Article Title"},{"value":"Phytomedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phymed.2026.158701","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier GmbH. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"158701"}}